Results 101 to 110 of about 15,109,420 (166)

Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study. [PDF]

BMJ Open
Khan ME, Ullah M, Khan MU, Bibi A, Tariq N, Mahnoor A, Rasool M, Nasir M, Sohaib RA, Ahmed W, Ali M, Nasir M, Nawaz U, Hurairah MA.   +13 more
europepmc   +1 more source

miR-34a and miR-223 as diagnostic biomarkers for the severity of non-alcoholic fatty liver disease. [PDF]

J Genet Eng Biotechnol
Alzubaidi AK, Al-Saadi FA, Fadhil YB.
europepmc   +1 more source

Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies. [PDF]

Life (Basel)
Katsaros I, Schizas D.
europepmc   +1 more source

Prevalence and Risk Factors of Celiac Disease in Patients With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. [PDF]

JGH Open
Keetha NR, Rashidian P, Fleischman M, Mohammadyari F, Ulrich MT, Hashemi SM, Balivada KS, Karimi MA, Letafatkar N, Amini-Salehi E, Nayak SS.   +10 more
europepmc   +1 more source

Bioinformatics and experimental validation of druggable targets in non-alcoholic fatty liver disease. [PDF]

Sci Rep
Zhang X, Su H, Zhou Q, Zhou Y.
europepmc   +1 more source

Evaluation of sleep quality and obstructive sleep apnea in non-alcoholic fatty liver disease: a cross-sectional study. [PDF]

BMC Gastroenterol
Ravanshad S, Golestani MN, Ahadi M, Kabiri M, Mehrad-Majd H, Saleh LA, Azinfar A, Rajabi M.   +7 more
europepmc   +1 more source

Sonographic Grading of Non-alcoholic Fatty Liver Disease and Its Association With Serum Biomarkers, Echocardiography, and Electrocardiogram. [PDF]

Cureus
Reddy C, L MMB, A S, Prasad S, Reddy CM.
europepmc   +1 more source

Eosinophilic Esophagitis and Risk of Non-Alcoholic Fatty Liver Disease and Cirrhosis: A Multi-Center Retrospective Study. [PDF]

Int J Med Sci
Gau SY, Su YJ, Yang SC, Wu CL, Chen SC, Chang HC, Wu MC.   +6 more
europepmc   +1 more source

Association of estimated pulse wave velocity with non-alcoholic fatty liver disease in multiple cohorts. [PDF]

iScience
Ji JJ, Yang Y, Zhang XY, Liu Y, Yang F, Qiao YL.   +5 more
europepmc   +1 more source

Liposomal Nanocarriers in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Formulation Design, Targeting Strategies, and Therapeutic Outcomes. [PDF]

Curr Issues Mol Biol
AlMotwaa SM, Al-Otaibi WA.
europepmc   +1 more source